Vi Partners is pleased to announce that our portfolio company, Vara, a pioneering AI-enabled early breast cancer detection platform, has successfully raised $8.9 million in funding. The round welcomed three new lead investors: European family offices Smart Family Office (Austria) and FJH (Germany), as well as Berlin-based healthcare investor IBB Ventures.

Since its initial deployment in 2019, Vara has demonstrated remarkable success within the German National Breast Cancer Screening Program. Today, nearly 40% of breast cancer screenings in Germany are managed on Vara's AI platform, making it the only AI system deployed at scale in the program. Key achievements include:

• Over 100,000 images assessed per month using Vara's AI

• Significantly increased cancer detection rates, including finding 50% of cancers that radiologists might have missed

• Reduced false positives

• Enhanced workflow efficiency for radiologists

Building on its success in Germany, Vara is expanding into emerging healthcare markets, including India. In 2023, the company partnered with NM Medical, a leading provider of imaging services in Mumbai, Bangalore, and Pune, to elevate the standard of preventive care and early breast cancer detection in the country.

Vi Partners congratulates Vara on this significant milestone. As an investor, we are proud to support their mission to improve early breast cancer detection through innovative AI technology. Their expansion into India represents a crucial step towards making life-saving screening more accessible on a global scale.